mhurhangee/ep-ind-claims huggingface dataset:
A synergistic therapeutic composition for use in the prevention, elimination, treatment and management of neurodegenerative and neuro muscular degenerative disorders and diseases in human and animal subjects, such as Amytrophic lateral sclerosis, Multiple sclerosis, Alzheimer's disease, Parkinson's disease, and Muscular dystrophy and others, comprising a first component and a second component, said first component being D-mannitol, and said second component being ascorbic acid in any of the forms selected among the oxidised form, the reduced form, the mineral ascorbates, the fatty acid esters of ascorbic acid, Vitamin C or DHA, or any of the mixtures of said forms.
A method of additively manufacturing a component, comprising: additively manufacturing a component with an internal passage, wherein the internal passage is non-line of sight, characterised in that the method further comprises: additively manufacturing a multiple of agitators within the internal passage concurrent with additively manufacturing the component, wherein each of the multiple of agitators are designed to a particular known natural frequency, the particular known natural frequency different than the natural frequencies of the component, vibrating the component at the particular known natural frequency of the multiple of agitators within the internal passage of the additively manufactured component such that the multiple of agitators operates to clean the internal passage of conglomerated powder. additively manufacturing a component with an internal passage, wherein the internal passage is non-line of sight, characterised in that the method further comprises: additively manufacturing a multiple of agitators within the internal passage concurrent with additively manufacturing the component, wherein each of the multiple of agitators are designed to a particular known natural frequency, the particular known natural frequency different than the natural frequencies of the component, vibrating the component at the particular known natural frequency of the multiple of agitators within the internal passage of the additively manufactured component such that the multiple of agitators operates to clean the internal passage of conglomerated powder. additively manufacturing a multiple of agitators within the internal passage concurrent with additively manufacturing the component, wherein each of the multiple of agitators are designed to a particular known natural frequency, the particular known natural frequency different than the natural frequencies of the component, vibrating the component at the particular known natural frequency of the multiple of agitators within the internal passage of the additively manufactured component such that the multiple of agitators operates to clean the internal passage of conglomerated powder.
A device configured to encode scene-based audio data, the device comprising: a memory configured to store the scene-based audio data, and one or more processors configured to: perform spatial audio encoding with respect to the scene-based audio data to obtain a foreground audio signal and a corresponding spatial component, the spatial component defining spatial characteristics of the foreground audio signal; perform psychoacoustic audio encoding with respect to the foreground audio signal to obtain an encoded foreground audio signal; determine, when performing psychoacoustic audio encoding with respect to the foreground audio signal, a bit allocation for the foreground audio signal; scale, based on the bit allocation for the foreground audio signal, the spatial component to obtain a scaled spatial component; quantize the scaled spatial component to obtain a quantized spatial component; and specify, in a bitstream, the encoded foreground audio signal and the quantized spatial component. a memory configured to store the scene-based audio data, and one or more processors configured to: perform spatial audio encoding with respect to the scene-based audio data to obtain a foreground audio signal and a corresponding spatial component, the spatial component defining spatial characteristics of the foreground audio signal; perform psychoacoustic audio encoding with respect to the foreground audio signal to obtain an encoded foreground audio signal; determine, when performing psychoacoustic audio encoding with respect to the foreground audio signal, a bit allocation for the foreground audio signal; scale, based on the bit allocation for the foreground audio signal, the spatial component to obtain a scaled spatial component; quantize the scaled spatial component to obtain a quantized spatial component; and specify, in a bitstream, the encoded foreground audio signal and the quantized spatial component. perform spatial audio encoding with respect to the scene-based audio data to obtain a foreground audio signal and a corresponding spatial component, the spatial component defining spatial characteristics of the foreground audio signal; perform psychoacoustic audio encoding with respect to the foreground audio signal to obtain an encoded foreground audio signal; determine, when performing psychoacoustic audio encoding with respect to the foreground audio signal, a bit allocation for the foreground audio signal; scale, based on the bit allocation for the foreground audio signal, the spatial component to obtain a scaled spatial component; quantize the scaled spatial component to obtain a quantized spatial component; and specify, in a bitstream, the encoded foreground audio signal and the quantized spatial component.
An article for transcutaneously applying electrical stimulation to target nerve tissue to treat a patient having peripheral neuropathy, the article comprising: a support on which at least one electrode pair (20, 28) is positioned, wherein the support is a wrap (97, 98), a sock, a glove, or a finger cot; a pulse generator attached to the at least one electrode (20, 28) pair via one or more leads; and a power supply connected to the pulse generator, wherein the article is configured to deliver electrical field stimulation to the target nerve tissue via the at least one electrode pair (20, 28) at a level sufficient to initiate vasodilation of vasculature within or adjacent the target nerve tissue, wherein the vasculature is responsible for perfusing the target nerve tissue, further wherein the article is configured to deliver the electrical stimulation at a current ranging from about 0.1 milliamps to about 60 milliamps. a support on which at least one electrode pair (20, 28) is positioned, wherein the support is a wrap (97, 98), a sock, a glove, or a finger cot; a pulse generator attached to the at least one electrode (20, 28) pair via one or more leads; and a power supply connected to the pulse generator, wherein the article is configured to deliver electrical field stimulation to the target nerve tissue via the at least one electrode pair (20, 28) at a level sufficient to initiate vasodilation of vasculature within or adjacent the target nerve tissue, wherein the vasculature is responsible for perfusing the target nerve tissue, further wherein the article is configured to deliver the electrical stimulation at a current ranging from about 0.1 milliamps to about 60 milliamps.
A molded product, formed by injection molding of a liquid crystalline resin composition including a fibrous filler and a liquid crystal polymer, the fibrous filler having an area that is exposed on a surface of the molded product, the area of the fibrous filler accounting for 0.3% or less of a surface area of the molded product, 2.5% or less of the fibrous filler included in the molded product having a fiber length of 200 μm or longer, and the fibrous filler included in the molded product having a number average fiber length of 76 μm or shorter, a surface Young's modulus of the molded product being measured in such a manner that Young's modulus of a part of the molded product in which part no fibrous filler is exposed was measured with FISCHER SCOPE (H100C by Fischer Instruments K.K.) under the following conditions: depth of measured point: 10 μm, test force: 150 mN, application: 10 seconds, and creep: 1 second, and the Young's modulus thus measured was used as the surface Young's modulus, the surface Young's modulus of the molded product being 2000 MPa or more and 3700 MPa or less.
An advanced composite blend comprising: (i) a di-phenylethynyl capped oligomer having the formula: D-A-D wherein A is an oligomer selected from the group consisting of imidesulfone, ether, ethersulfone, amide, imide, ester, estersulfone, etherimide, amideimide, oxazole, oxazole sulfone, thiazole, thiazole sulfone, imidazole, and imidazole sulfone; and D is a di-phenylethynyl endcap, formed by reaction of an oligomer A with a di-phenylethynyl endcap monomer having the formula: or or wherein Φ = phenyl; G=-SOZ-,-S-,-O-,-CH 2 -,-CO-,-SO-, C 3 F 6, or NHCO; and R 1 = amine, hydroxyl, acid chloride, or anhydride, where R 1 is the point of attachment to A; and (ii) at least one compatible polymer from a different chemical family than the oligomer. (i) a di-phenylethynyl capped oligomer having the formula: D-A-D wherein A is an oligomer selected from the group consisting of imidesulfone, ether, ethersulfone, amide, imide, ester, estersulfone, etherimide, amideimide, oxazole, oxazole sulfone, thiazole, thiazole sulfone, imidazole, and imidazole sulfone; and D is a di-phenylethynyl endcap, formed by reaction of an oligomer A with a di-phenylethynyl endcap monomer having the formula: or or wherein Φ = phenyl; G=-SOZ-,-S-,-O-,-CH 2 -,-CO-,-SO-, C 3 F 6, or NHCO; and R 1 = amine, hydroxyl, acid chloride, or anhydride, where R 1 is the point of attachment to A; and A is an oligomer selected from the group consisting of imidesulfone, ether, ethersulfone, amide, imide, ester, estersulfone, etherimide, amideimide, oxazole, oxazole sulfone, thiazole, thiazole sulfone, imidazole, and imidazole sulfone; and D is a di-phenylethynyl endcap, formed by reaction of an oligomer A with a di-phenylethynyl endcap monomer having the formula: or or wherein Φ = phenyl; G=-SOZ-,-S-,-O-,-CH 2 -,-CO-,-SO-, C 3 F 6, or NHCO; and R 1 = amine, hydroxyl, acid chloride, or anhydride, where R 1 is the point of attachment to A; and Φ = phenyl; G=-SOZ-,-S-,-O-,-CH 2 -,-CO-,-SO-, C 3 F 6, or NHCO; and R 1 = amine, hydroxyl, acid chloride, or anhydride, where R 1 is the point of attachment to A; and (ii) at least one compatible polymer from a different chemical family than the oligomer.
Elastic floor covering in form of a web product that can be rolled up, comprising a soft core of polyurethane and a layered compound structure disposed on the core, characterized in that the back of the floor covering is formed by a fiber mat, the fibers of which consist of glass, PET, PP, polyester or renewable raw materials and which is sealed on the side facing the core by a barrier layer.
An in vitro method for assessing whether a human patient has gingivitis, wherein the method comprises: - detecting, in a sample of saliva from said human patient, the concentrations of the proteins Alpha-1-acid glycoprotein (A1AGP), S100 calcium-binding protein A8 (S100A8) and Keratin 4 (K-4); - determining a testing value reflecting the joint concentrations determined for said proteins; - comparing said testing value with a threshold value reflecting in the same manner the joint concentrations associated with gingivitis, so as to assess whether the testing value is indicative for gingivitis in said patient. - detecting, in a sample of saliva from said human patient, the concentrations of the proteins Alpha-1-acid glycoprotein (A1AGP), S100 calcium-binding protein A8 (S100A8) and Keratin 4 (K-4); - determining a testing value reflecting the joint concentrations determined for said proteins; - comparing said testing value with a threshold value reflecting in the same manner the joint concentrations associated with gingivitis, so as to assess whether the testing value is indicative for gingivitis in said patient.
An air vent assembly (200, 201) for a helmet, the air vent assembly comprising: a vent body (236, 237) including a vent border (202, 203) and a vent base (204, 205) receded from the vent border, the vent base comprising at least one opening through the vent base, the vent base and the vent border forming a recess (230, 231); a vent cover (226,227) pivotally coupled to the vent base by at least a cover anchor, the vent cover configured to pivot between an open position and a closed position about a pivoting axis extending between the at least a cover anchor, the vent cover covering at least a majority of the recess when the vent cover is in the closed position; and being characterized by at least a first magnet (208,209) disposed on at least one of the vent cover and the vent body, and at least a second magnet or attractor disposed on the other of the vent cover and the vent body opposite the at least a first magnet; wherein the vent cover pivots to the open position through interaction between the at least a first magnet and the at least a second magnet or attractor when first pressure is exerted upon a first portion of the vent cover, and the vent cover pivots to the closed position through the interaction between the at least a first magnet and the at least a second magnet or attractor when pressure is exerted upon a second portion of the vent cover opposite the first portion. a vent body (236, 237) including a vent border (202, 203) and a vent base (204, 205) receded from the vent border, the vent base comprising at least one opening through the vent base, the vent base and the vent border forming a recess (230, 231); a vent cover (226,227) pivotally coupled to the vent base by at least a cover anchor, the vent cover configured to pivot between an open position and a closed position about a pivoting axis extending between the at least a cover anchor, the vent cover covering at least a majority of the recess when the vent cover is in the closed position; and being characterized by at least a first magnet (208,209) disposed on at least one of the vent cover and the vent body, and at least a second magnet or attractor disposed on the other of the vent cover and the vent body opposite the at least a first magnet; wherein the vent cover pivots to the open position through interaction between the at least a first magnet and the at least a second magnet or attractor when first pressure is exerted upon a first portion of the vent cover, and the vent cover pivots to the closed position through the interaction between the at least a first magnet and the at least a second magnet or attractor when pressure is exerted upon a second portion of the vent cover opposite the first portion.
A shipping container for transporting at least one cryogenically cooled super-conducting magnet (12 A, 12 B) on a transportation vehicle, comprising: a cryogenic refrigeration system which monitors the temperature and/or pressure of the cryogenically cooled super-conducting magnet and circulates a refrigerant to the cryogenically cooled super-conducting magnet to maintain cryogenic temperatures; and a power inlet accessible from an exterior of the shipping container, the power inlet connects power to the cryogenic refrigeration system from an external power supply provided by the transportation vehicle and characterised in that the cryogenic refrigeration system, includes: at least one refrigeration unit (34 A, 34 B) which cools heated refrigerant and circulates the cooled refrigerant to a cold head (22 A, 22 B) of each super-conducting magnet (12 A, 12 B); a control and monitoring unit which receives a temperature and/or a pressure signal from the at least one super-conducting magnet (12 A, 12 B) and controls each compressor to maintain desired a temperature and/or pressure; and a display unit visible from the exterior of the shipping container which displays data regarding parameters of the cryogenic refrigeration system. a cryogenic refrigeration system which monitors the temperature and/or pressure of the cryogenically cooled super-conducting magnet and circulates a refrigerant to the cryogenically cooled super-conducting magnet to maintain cryogenic temperatures; and a power inlet accessible from an exterior of the shipping container, the power inlet connects power to the cryogenic refrigeration system from an external power supply provided by the transportation vehicle and characterised in that the cryogenic refrigeration system, includes: at least one refrigeration unit (34 A, 34 B) which cools heated refrigerant and circulates the cooled refrigerant to a cold head (22 A, 22 B) of each super-conducting magnet (12 A, 12 B); a control and monitoring unit which receives a temperature and/or a pressure signal from the at least one super-conducting magnet (12 A, 12 B) and controls each compressor to maintain desired a temperature and/or pressure; and a display unit visible from the exterior of the shipping container which displays data regarding parameters of the cryogenic refrigeration system. at least one refrigeration unit (34 A, 34 B) which cools heated refrigerant and circulates the cooled refrigerant to a cold head (22 A, 22 B) of each super-conducting magnet (12 A, 12 B); a control and monitoring unit which receives a temperature and/or a pressure signal from the at least one super-conducting magnet (12 A, 12 B) and controls each compressor to maintain desired a temperature and/or pressure; and a display unit visible from the exterior of the shipping container which displays data regarding parameters of the cryogenic refrigeration system.
A method for detecting at least one microorganism present in a sample, comprising: - culturing the sample in a liquid medium in the presence of at least one ligand specific for the microorganism and at least one sensor that is not specific for the microorganism, the binding of said microorganism to the ligand producing a first measurable signal and the binding of said microorganism to the sensor producing a second measurable signal; - determining values of the first and second signals for at least one culture time; wherein it is deduced that the sample comprises the microorganism when the values of the first signal and of the second signal are different for the same culture time. - culturing the sample in a liquid medium in the presence of at least one ligand specific for the microorganism and at least one sensor that is not specific for the microorganism, the binding of said microorganism to the ligand producing a first measurable signal and the binding of said microorganism to the sensor producing a second measurable signal; - determining values of the first and second signals for at least one culture time;
Earthquake alert system having two or more sensors for detecting tremor signals, and having means for electrical signal processing for processing and analyzing the tremor signals, the system comprises at least two detection units (1, 2) that each have a tremor sensor and electronic signal processing means, in each instance, whereby the signal processing means of each detection unit (1, 2) are set up in such a manner that they detect primary waves of earthquakes on the basis of the signal of the tremor sensor, and whereby the detection units (1, 2) are connected with one another by way of an electronic data bus, characterized in that, the detection units (1, 2) communicate with one another in master/slave mode, by way of the data bus, specifically in such a manner that a detection unit being operated in master mode periodically queries the detection units being operated in slave mode, whereby the detection unit being operated in master mode is set up in such a manner that it activates the alarm as a function of the result of the query to the detection units being operated in slave mode, whereby detection units (1,2) are set up that each of the detection units (1,2) connected to one another via the data bus can be operated in master mode or in slave mode, whereby a detection unit, operated in slave mode, automatically assumes the function of a master as soon as a detection unit, operated in master mode, fails or its connection to the data bus is interrupted.
A topical skin care composition, comprising: a. 0.01% to 15% niacinamide; b. 0.01% to 15% of a saccharide, and said saccharide is ribose; c. a pH of less than 4.0; and d. a dermatologically acceptable carrier. a. 0.01% to 15% niacinamide; b. 0.01% to 15% of a saccharide, and said saccharide is ribose; c. a pH of less than 4.0; and d. a dermatologically acceptable carrier.
A compound of the formula: A U M 1 V M 2 W M 3 X M 4 Y M 5 Z O 2 wherein A is one or more alkali metals comprising sodium and/or potassium either alone or in a mixture with lithium as a minor constituent; M 1 is nickel in oxidation state +2 M 2 comprises a metal in oxidation state +4 selected from one or more of manganese, titanium and zirconium; M 3 comprises a metal in oxidation state +2, selected from one or more of magnesium, calcium, copper, zinc and cobalt; M 4 comprises a metal in oxidation state +4, selected from one or more of titanium, manganese and zirconium; M 5 comprises a metal in oxidation state +3, selected from one or more of aluminium, iron, cobalt, molybdenum, chromium, vanadium, scandium and yttrium; further wherein U is in the range 1 < U < 2; V is in the range 0.25 < V < 1; W is in the range 0 < W < 0.75; X is in the range 0:5 X < 0.5; Y is in the range 0 ≤ Y < 0.5; Z is in the range 0 ≤ Z < 0.5; and further wherein U+V+W+X+Y+Z≤3 A is one or more alkali metals comprising sodium and/or potassium either alone or in a mixture with lithium as a minor constituent; M 1 is nickel in oxidation state +2 M 2 comprises a metal in oxidation state +4 selected from one or more of manganese, titanium and zirconium; M 3 comprises a metal in oxidation state +2, selected from one or more of magnesium, calcium, copper, zinc and cobalt; M 4 comprises a metal in oxidation state +4, selected from one or more of titanium, manganese and zirconium; M 5 comprises a metal in oxidation state +3, selected from one or more of aluminium, iron, cobalt, molybdenum, chromium, vanadium, scandium and yttrium; further wherein U is in the range 1 < U < 2; V is in the range 0.25 < V < 1; W is in the range 0 < W < 0.75; X is in the range 0:5 X < 0.5; Y is in the range 0 ≤ Y < 0.5; Z is in the range 0 ≤ Z < 0.5; and further wherein U+V+W+X+Y+Z≤3
An upper body appendage support apparatus comprising at least one articulating support structure; an upper body appendage support structure movably attached to the articulating support structure; the upper body appendage support structure comprising a surface (37a,37b) on which at least a portion of user upper body appendage can rest; wherein the articulating support structure is configured to counteract the weight of the upper body appendage support structure and any weight thereon by providing a lifting force; the upper body appendage support structure comprising a two section (47,48) upper body appendage support structure, wherein a first section is configured to accommodate a user forearm and a second section is configured to accommodate an appendage portion below the user forearm, characterized in that the upper body appendage support structure comprises one or more roll mechanisms (32, 35) to allow rotation of user upper body appendages about an axis substantially parallel to the user forearm without lifting from, or sliding on upper body appendage support structure resting surface (37a,37b).